Stay updated on Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:09:15.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-24T13:37:34.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T13:37:58.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The revision identifier in the footer changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-10T14:42:59.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A 403 Forbidden page now replaces the study record for the NCT04740918 entry, displaying a 403 message and basic navigation. The detailed study content and documents are no longer accessible through the page.
    Difference
    19%
    Check dated 2026-09-19T19:22:31.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a minor update in the page's versioning metadata without changes to study details.
    Difference
    0.0%
    Check dated 2026-09-05T20:34:25.000Z thumbnail image

Stay in the know with updates to Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab-Emtansine & Atezolizumab in HER2+ LABC/MBC Clinical Trial page.